KEY PRODUCTS
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 6STRIDES PHARMA INTL
01 611491125
01 6Blank
01 6Y
01 62041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3488
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Patent Expiration Date : 2041-09-29
US Patent Number : 11491125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 215422
Patent Use Code : U-3489
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-09-29
